Can You Take Metoprolol and Diltiazem Together?

Yes, you can take metoprolol and diltiazem together, but this combination is classified as a major drug interaction by the FDA and requires careful monitoring. Both medications work to slow your heart rate and reduce blood pressure, and when taken together, their effects can add up—sometimes to the point of causing dangerously slow heart rate (bradycardia) or conduction problems. Your doctor may prescribe both drugs if the benefits outweigh the risks, but you need to know what to watch for and when to contact your healthcare team.

What the FDA Says

The FDA classifies the interaction between metoprolol and diltiazem as major severity. According to FDA drug labeling data, the concomitant use of these two medications increases the risk of bradycardia—an abnormally slow heart rate—because both agents depress atrioventricular (AV) conduction and decrease heart rate through different but complementary mechanisms. The FDA labels for both metoprolol and diltiazem specifically warn against combining them without medical supervision and dose adjustment.

This is not a contraindication—meaning doctors do prescribe both drugs together when clinically necessary—but it is flagged as requiring enhanced monitoring. Your pharmacist and doctor need to actively manage this combination, not simply ignore it.

How This Interaction Works

To understand why metoprolol and diltiazem together pose a risk, you need to know how each drug works independently.

Metoprolol is a beta-1 selective adrenergic blocker. It works by blocking the effects of the hormone epinephrine (adrenaline) on your heart's beta-1 receptors. This slows the electrical impulses in your heart, reduces how fast your heart beats, and lowers blood pressure. Metoprolol is commonly prescribed for high blood pressure, angina, and heart failure.

Diltiazem is a non-dihydropyridine calcium channel blocker. It works by blocking calcium channels in the walls of your arteries and in your heart's electrical system. This dilates your blood vessels, reduces heart workload, and also slows conduction through the atrioventricular (AV) node—the electrical gateway between the upper chambers (atria) and lower chambers (ventricles) of your heart.

When you take both medications, their effects are additive. Both are suppressing the same electrical activity in your heart, but through different molecular pathways. The AV node—which is particularly sensitive to both beta blockers and non-dihydropyridine calcium channel blockers—receives a "double hit" of suppression. This can result in:

• Bradycardia (heart rate below 60 bpm, sometimes much lower)
• First-degree AV block (delayed conduction between atria and ventricles)
• Second-degree AV block (some atrial impulses fail to reach the ventricles)
• High-degree AV block or complete heart block (in severe cases)
• Syncope (fainting) due to insufficient cardiac output
• Worsening heart failure (paradoxically, despite both drugs being used for heart failure)

The risk is greatest when doses are high, when renal or hepatic function is impaired, or when the patient has pre-existing conduction abnormalities.

Who Is Most at Risk

Not everyone who takes both metoprolol and diltiazem will experience a serious interaction. Your individual risk depends on several factors:

• Baseline heart rate and conduction status: If you already have a slow heart rate, history of AV block, or other electrical conduction problems, you are at much higher risk. Pre-existing conduction disease is the single biggest risk factor.
• Age: Older adults (over 65) have naturally slower heart rates and more fragile electrical systems. The risk of symptomatic bradycardia is higher in this population.
• Kidney or liver disease: Both metoprolol and diltiazem are metabolized by the liver and cleared by the kidneys. If your kidneys or liver aren't working well, these drugs can accumulate to toxic levels.
• Dosage: High doses of either or both drugs increase risk more than low doses.
• Other medications: If you're also taking digoxin, amiodarone, verapamil, or other drugs that slow heart rate or AV conduction, the risk multiplies.
• Hypotension: If you already struggle with low blood pressure, the combination can make it worse.
• Acute illness: Infection, sepsis, or acute decompensated heart failure can interact with these medications unpredictably.

Clinical Scenario 1: Safe Combination with Monitoring

Maria is a 62-year-old woman with hypertension and stable angina. Her cardiologist prescribed her diltiazem 240 mg daily (sustained-release) several years ago, and her blood pressure and chest pain have been well controlled. Six months ago, Maria had a heart attack, and her cardiologist added metoprolol 50 mg twice daily to improve her heart's recovery and reduce her risk of another event. Her baseline heart rate before starting metoprolol was around 70 bpm.

Maria's cardiologist was aware of the interaction and made a deliberate choice to use both drugs because:

• The cardioprotective benefits after heart attack (beta blocker) outweighed the interaction risk
• Maria's kidney and liver function were normal
• Her baseline heart rate was not slow
• An EKG before starting metoprolol showed no AV conduction abnormality
• Her baseline blood pressure was 145/88—high enough that the combined BP-lowering effect was beneficial

Maria's doctor ordered an EKG and had her check her heart rate at home twice weekly for the first month. Her heart rate settled at around 55 bpm, which is acceptable. She has no symptoms of dizziness, syncope, or fatigue. She sees her cardiologist every three months for EKG monitoring. In Maria's case, the combination is appropriate and manageable.

Clinical Scenario 2: High-Risk Combination Requiring Intervention

Robert is a 78-year-old man with a long history of hypertension, atrial fibrillation, and mild heart failure. He has been on diltiazem 180 mg daily for ten years, primarily to control his heart rate during atrial fibrillation and to manage blood pressure. His baseline heart rate has been stable at around 60-65 bpm. Last month, his primary care doctor prescribed metoprolol 25 mg daily for additional heart rate control during his atrial fibrillation episodes, without informing his cardiologist.

Two weeks later, Robert's daughter brings him to the emergency department because he has been feeling lightheaded for several days, has nearly fainted twice, and his wife noticed his heart "seems to be skipping beats." An EKG shows a heart rate of 38 bpm with first-degree AV block and signs of second-degree AV block. His blood pressure is 95/60.

In Robert's case, the combination was inappropriate because:

• He was 78 years old with baseline bradycardia and pre-existing AV conduction abnormality (atrial fibrillation with variable ventricular response)
• His baseline heart rate of 60-65 bpm left little room for additional slowing
• The dose of metoprolol was not adjusted to account for his age and existing diltiazem therapy
• There was no baseline EKG comparison or close follow-up

Robert's metoprolol was discontinued immediately, and his heart rate gradually improved. He remained on diltiazem alone, which was adequate for his rate control. This scenario illustrates why careful patient selection and baseline testing are essential.

What to Do: Management Guidance for Patients

If your doctor has prescribed both metoprolol and diltiazem:

1. Ask specific questions at the pharmacy: Tell your pharmacist that you're taking both a beta blocker and a calcium channel blocker. Ask them to review the interaction and confirm that your doctor is aware. A good pharmacist will have already flagged this and may contact your doctor proactively.
2. Get a baseline EKG: Before starting either drug (or when combining them), ask your doctor for a baseline EKG. This gives you and your doctor a reference point to compare against if you develop symptoms.
3. Know your baseline heart rate: Take your pulse before you start the drugs and record it. Learn where to take your pulse (inner wrist on the thumb side, or on the side of your neck), and check it regularly—ideally at the same time each day, usually in the morning before getting out of bed.
4. Never adjust the dose yourself: Do not increase, decrease, or stop either medication without explicit instruction from your doctor, even if you feel your heart rate is too low. Stopping suddenly can cause rebound high blood pressure or worsening angina.
5. Keep all follow-up appointments: Your doctor may want to see you within 1-2 weeks of starting the combination, then monthly for the first few months, then quarterly. This is not optional—it's how your doctor monitors for silent conduction problems.
6. Report other medications immediately: If a different doctor prescribes any new medication—including over-the-counter drugs, supplements, or herbal products—tell them you're on both metoprolol and diltiazem. Drugs like NSAIDs, decongestants, and certain herbal supplements can interact with these medications.
7. Avoid activity suddenly: Both drugs can reduce your exercise capacity. If you exercise, do it slowly and watch for dizziness or chest pain. Stop if you feel unwell.

When to Call Your Doctor or Pharmacist

Call or seek immediate medical attention if you experience any of the following:

• Syncope or near-syncope: Fainting or feeling like you're about to faint is a red flag for dangerous bradycardia or AV block. This is not normal and requires urgent evaluation.
• Dizziness or lightheadedness that's new or worsening: Especially if it happens multiple times a day or with minimal activity.
• Chest pain, pressure, or tightness: This could indicate worsening angina due to reduced cardiac output, or it could indicate a heart attack. Call 911 if severe.
• Shortness of breath at rest or with minimal exertion: Both drugs can worsen heart failure in some patients.
• Heart palpitations or feeling like your heart is "skipping" or "racing": Paradoxically, excessive AV block can cause atrial fibrillation or other arrhythmias.
• Unusual fatigue or weakness: This can signal a heart rate that's too slow to maintain adequate blood circulation to your brain and muscles.
• Swelling in your legs, feet, or abdomen: A sign of worsening heart failure.
• Persistent low blood pressure (below 90/60): Check your blood pressure at home if you have a monitor. If it's consistently below 90/60 and you feel unwell, contact your doctor.
• New or worsening confusion: A very slow heart rate can reduce blood flow to your brain.

Call your doctor within 24 hours if:

• Your resting heart rate drops below 50 bpm and stays there
• You feel more tired than usual for more than a few days
• You have mild dizziness that goes away with rest but keeps recurring
• You want to stop one of the medications because of side effects

Your pharmacist can often answer questions about side effects and drug interactions before you need to reach your doctor. They're your first line of defense.

Key Takeaways

• The combination is classified as major severity by the FDA, but it's not absolutely forbidden. Doctors prescribe both drugs together when the cardiovascular benefits outweigh the interaction risk, particularly after heart attack or in certain heart failure patients.
• The interaction works through additive effects on your heart's electrical system. Both drugs slow conduction through the AV node, and together they can cause bradycardia, AV block, syncope, and worsening heart failure.
• Your risk depends on age, baseline heart rate, kidney/liver function, dosage, and other medications. Older adults with pre-existing conduction problems are at highest risk. Ask your doctor why you specifically need both drugs.
• Close monitoring is essential. Get a baseline EKG, know your normal heart rate, attend all follow-up appointments, and learn the red flag symptoms. Do not adjust doses on your own.
• Your pharmacist is your partner. They will flag this interaction and should actively communicate with your doctor. Use them as a resource before calling your doctor for minor questions.

Sources

• FDA Drug Labeling via OpenFDA: open.fda.gov (Metoprolol and Diltiazem drug labels)
• National Library of Medicine, PubMed Central: Drug interaction studies on beta-blockers and calcium channel blockers (https://www.ncbi.nlm.nih.gov/pmc/)
• American Heart Association: Guidelines on antiarrhythmic and cardioprotective drug interactions (https://www.heart.org/)
• Lexicomp (UpToDate): Metoprolol-Diltiazem Interaction Severity Classification
• Clinical Pharmacology Reference: Additive negative chronotropic effects and AV conduction depression

Understanding your medications is the first step to staying safe. If you're taking metoprolol, diltiazem, or any combination of heart medications, don't guess about interactions. Visit checkdruginteractions.com to check your complete medication list against over 250,000 FDA drug labels. You can also upload a photo of all your medicine bottles, and our tool will instantly flag any major or moderate interactions, show you the FDA severity data, and tell you exactly which symptoms to watch for. Your health is too important for guesswork—get clarity today.